Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001354069 | SCV002353030 | benign | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001354069 | SCV001548591 | uncertain significance | not provided | no assertion criteria provided | clinical testing | The FN1 c.6487+12C>G variant was not identified in the literature nor was it identified in ClinVar, Cosmic, MutDB or LOVD 3.0. The variant was identified in dbSNP (ID: rs111303746) with clinical significance as "NA". The variant was identified in control databases in 41 of 282824 chromosomes at a frequency of 0.000145 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 38 of 24958 chromosomes (freq: 0.001523), Other in 1 of 7226 chromosomes (freq: 0.000138), Latino in 1 of 35438 chromosomes (freq: 0.000028) and European (non-Finnish) in 1 of 129160 chromosomes (freq: 0.000008), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish) or South Asian populations. The variant occurs outside of the splicing consensus sequence however 4 of 4 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) predict a greater than 10% difference in splicing and the creation of a 5' splice site. This information is not predictive enough to assume pathogenicity. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |